Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J, Zhuang C, Liu Y, Chen M, Chen Y, Chen Z, He A, Lin J, Zhan Y, Liu L, Xu W, Zhao G, Guo Y, Wu H, Cai Z, Huang W.
Li J, et al. Among authors: liu y, liu l.
J Exp Clin Cancer Res. 2023 Nov 28;42(1):321. doi: 10.1186/s13046-023-02908-6.
J Exp Clin Cancer Res. 2023.
PMID: 38012784
Free PMC article.
No abstract available.